Geneoscopy, a St. Louis-based developer of diagnostic tests for GI health, raised $105 million in Series B equity and debt funding, per Axios. Insiders Lightchain Capital and NT Investments co-led, and were joined by Morningside Ventures, Labcorp, Cultivation Capital, BioGenerator Ventures and Innovatus Capital Partners.
Related Posts
Jupiter Wellness Acquisition Files for $100M IPO
The new SPAC will seek a target in the healthcare industry with an equity value of approximately $300 million to $1 billion.
November 2, 2021
LifePoint Health to Lead Investment in Specialist TeleMed
STeM is a multi-specialty telemedicine provider for hospitals, clinics and remote locations worldwide.
April 22, 2022
Hospital for Special Surgery Launches New PT Company with $21M A Round
Flare Capital and HSS led the round.
December 6, 2022